Recruiting Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis NCT07249840 Conditions Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more Locations Mass General Brigham — Boston, Massachusetts, United States View Trial Details
Completed Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients NCT04243122 Conditions Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more Locations The Ottawa Hospital — Ottawa, Ontario, Canada View Trial Details
